Joseph Y. Chang - 14 Feb 2023 Form 4 Insider Report for NU SKIN ENTERPRISES, INC. (NUS)

Role: Chief Scientific Officer
Signature: /s/ Gregory Belliston as Attorney-in-Fact for Joseph Y. Chang
Issuer symbol: NUS
Transactions as of: 14 Feb 2023
Net transactions value: -$89,898
Form type: 4
Filing time: 16 Feb 2023, 17:14:45 UTC
Previous filing: 20 Dec 2022
Next filing: 03 Mar 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NUS	Class A Common Stock	Tax liability	$89,898	-1,981	-8.5%	$45.38	21,234	15 Feb 2023	Direct	F1
holding	NUS	Class A Common Stock						78,068	14 Feb 2023	Held in irrevocable family trust	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NUS	Employee Stock Option (Right to Buy)	Award	$0	+17,692	+27%	$0.000000	83,810	14 Feb 2023	Class A Common Stock	17,692	$30.45	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares withheld to cover tax withholding obligations related to the vesting of previously granted restricted stock units.
F2	This report should not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
F3	On February 15, 2020, the reporting person was granted stock options to purchase shares of Class A Common Stock, the vesting of which was contingent on Nu Skin Enterprises, Inc.'s satisfaction of certain performance criteria. On February 14, 2023, the performance criteria were met, resulting in the vesting of the amount shown above.